Gyre Therapeutics (GYRE) FCF Margin Growth (5y) (2015 - 2026)
Gyre Therapeutics (GYRE) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 171,921.00 |
| Mar 31, 2026 | 167,368.00 |
| Dec 31, 2025 | 107,341.00 |
| Sep 30, 2025 | 149,136.00 |
| Jun 30, 2025 | 92,087.00 |
| Mar 31, 2025 | 2,823.00 |
| Mar 31, 2023 | 8.85 Mn |
| Dec 31, 2022 | 203,444.00 |
| Mar 31, 2022 | 6,724.00 |
| Dec 31, 2021 | 644,580.00 |
| Sep 30, 2021 | 374,640.00 |
| Jun 30, 2021 | 177,923.00 |
| Mar 31, 2021 | 277,369.00 |
| Dec 31, 2020 | 371,852.00 |
| Sep 30, 2020 | 735,545.00 |
| Jun 30, 2020 | -75,473.00 |
| Mar 31, 2020 | 41,408.00 |
| Mar 31, 2018 | -8.82 Mn |
| Dec 31, 2017 | 655.00 |
| Sep 30, 2017 | -19,531.00 |